Clinical Trial

Network Pharmacology Was Applied to Explore the Mechanism of Remimazolam Applied in General Anesthesia for Gynecological Surgeries

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 25, 2025 (before its estimated December 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
To explore the related mechanisms by which remimazolam regulates hemodynamic stability, inflammatory factors and the immune system in patients undergoing general anesthesia for gynecological surgeries.
Trial Details
NCT Number NCT06990763
Lead Sponsor Second Hospital of Shanxi Medical University
Conditions Gynecological Disease
Enrollment 40 participants
Start Date 2025-06-01
Primary Completion 2025-12-01 (estimated)
Study Completion 2026-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-05-25